TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 34155773

Group type: EXPERIMENTAL
Intervention: Electronic Medical Record (EMR)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: My Health Record (MHR)
Number of subjects: 200

Group type: COMPARATOR
Intervention: EMR and MHR
Number of subjects: 200
Study: 33283581

Group type: EXPERIMENTAL
Intervention: Focused shock waves (F-SW) 1500 shocks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Radial shock waves (R-SW) 2000 shocks
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Combined focused and radial shock waves (C-SW)
Number of subjects: 45
Study: 34806486

Group type: EXPERIMENTAL
Intervention: Bolus feeding (BF group, n=24)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Continuous feeding (CF group, n=22)
Number of subjects: 46
Study: 33704620

Group type: EXPERIMENTAL
Intervention: Doxorubicin 40 mg/m2 and lurbinectedin 2.0 mg/m2 on Day 1 q3wk
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Doxorubicin 40 mg/m2 and lurbinectedin 2.0 mg/m2 on Day 1 q3wk in sensitive disease
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Doxorubicin 40 mg/m2 and lurbinectedin 2.0 mg/m2 on Day 1 q3wk in resistant disease
Number of subjects: 28
Study: 32914838

Group type: EXPERIMENTAL
Intervention: Text messaging-based HPV vaccination intervention (txt2protect)
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control condition messages focused on a variety of sexual health practices
Number of subjects: 150
Study: 32852553

Group type: EXPERIMENTAL
Intervention: Education and personalized text message reminders daily to prompt directly supervised therapy (intervention group)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Education alone (control group)
Number of subjects: 444
Study: 33528110

Group type: EXPERIMENTAL
Intervention: Partially guided template (test group 1, 36 implants)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fully guided template (test group 2, 33 implants)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine implant‐supported restoration treatment (control group, 30 implants)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Partially guided template (test group 1)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Fully guided template (test group 2)
Number of subjects: 60
Study: 32875431

Group type: EXPERIMENTAL
Intervention: 2D convolutional neural network (CNN) using sagittal scans from the SCIENCe cohort.
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: 2D convolutional neural network (CNN) using ADNI scans as test set.
Number of subjects: 155
Study: 35963146

Group type: EXPERIMENTAL
Intervention: High salience of base-rate information
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Low salience of base-rate information
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Health-related problems
Number of subjects: 368

Group type: EXPERIMENTAL
Intervention: Health-neutral problems
Number of subjects: 368
Study: 33307847

Group type: EXPERIMENTAL
Intervention: Full Moon (FM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: New Moon (NM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Static exercise during New Moon (NM)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Static exercise during Full Moon (FM)
Number of subjects: 42

Group type: COMPARATOR
Intervention: First Quarter (FQ)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Third Quarter (TQ)
Number of subjects: 42
Study: 35504257

Group type: EXPERIMENTAL
Intervention: CARS system
Number of subjects: 163

Group type: COMPARATOR
Intervention: FDI recurrence of caries
Number of subjects: 163

Group type: COMPARATOR
Intervention: FDI marginal adaptation
Number of subjects: 163

Group type: COMPARATOR
Intervention: FDI marginal staining
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Follow-up restorations
Number of subjects: 163
Study: 33771945

Group type: EXPERIMENTAL
Intervention: 6% carbohydrate (CHO) drink
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 32862007

Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (40 i.u.)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 36892754

Group type: EXPERIMENTAL
Intervention: Fesoterodine 4 mg once daily (QD) for patients weighing 25–35 kg
Number of subjects: 142

Group type: EXPERIMENTAL
Intervention: Fesoterodine 8 mg once daily (QD) for patients weighing > 35 kg
Number of subjects: 142

Group type: COMPARATOR
Intervention: Fesoterodine 8 mg once daily (QD) for adults
Number of subjects: 142
Study: 33106606

Group type: EXPERIMENTAL
Intervention: PEG‐ELS 40 (40 ml/kg)
Number of subjects: 150

Group type: COMPARATOR
Intervention: PEG‐ELS 60 (60 ml/kg)
Number of subjects: 150
Study: 34900203

Group type: EXPERIMENTAL
Intervention: Whole-Body Vibration Training (WBVT)
Number of subjects: 32
Study: 32579674

Group type: EXPERIMENTAL
Intervention: Kinship judgments (related or unrelated)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Similarity judgments (scale from 0 to 10)
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Kinship judgments
Number of subjects: 318

Group type: EXPERIMENTAL
Intervention: Similarity judgments
Number of subjects: 318
Study: 34407645

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Ibuprofen
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 32250198

Group type: EXPERIMENTAL
Intervention: Metoprolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35382059

Group type: EXPERIMENTAL
Intervention: IV dexmedetomidine 1 µg/kg over 10 min
Number of subjects: 60

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 60
Study: 33740610

Group type: EXPERIMENTAL
Intervention: Quantitative Index (QI)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Qualitative Evaluation (QE)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Overall Adequacy Assessment (OAA)
Number of subjects: 155
Study: 35266219

Group type: EXPERIMENTAL
Intervention: FGE dark chocolate (5 g/day containing 650 mg of FGE powder)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 32016118

Group type: EXPERIMENTAL
Intervention: Intravitreal Bevacizumab (IVB) plus topical dorzolamide 2% twice daily
Number of subjects: 16

Group type: COMPARATOR
Intervention: Intravitreal Bevacizumab (IVB) alone plus topical artificial tear twice daily
Number of subjects: 16
Study: 34081625

Group type: EXPERIMENTAL
Intervention: Psyllium husk
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 32030910

Group type: EXPERIMENTAL
Intervention: Self-regulation intervention
Number of subjects: 340

Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 340
Study: 616791213

Group type: EXPERIMENTAL
Intervention: Sanitary pad containing potassium alum
Number of subjects: 16

Group type: COMPARATOR
Intervention: Ordinary sanitary pads
Number of subjects: 16
Study: 35260538

Group type: EXPERIMENTAL
Intervention: Water with electrolytes (169 oz / 5L)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Plain water (169 oz / 5L)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group (not specified, but implied as baseline monitoring)
Number of subjects: 30
Study: 33039340

Group type: EXPERIMENTAL
Intervention: Hydralazine-isosorbide dinitrate
Number of subjects: 1500

Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 1500

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1500
Study: 32602065

Group type: EXPERIMENTAL
Intervention: Ceftazidime–avibactam ± metronidazole
Number of subjects: 4050

Group type: COMPARATOR
Intervention: Comparator
Number of subjects: 4050
Study: 36082955

Group type: EXPERIMENTAL
Intervention: Power prior models applied to first stage outcomes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fisher's Exact Test
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bhattacharyya's overlap measure
Number of subjects: 0
Study: 32034024

Group type: EXPERIMENTAL
Intervention: Helping Families Programme‐Modified (HFP‐M)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care (standard care augmented by a single psychoeducational parenting session)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: HFP‐M
Number of subjects: 48

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 48
Study: 33476595

Group type: EXPERIMENTAL
Intervention: Cytoreductive surgery plus HIPEC (360 mg/m2 closed abdomen or 460 mg/m2 open abdomen)
Number of subjects: 265

Group type: COMPARATOR
Intervention: Cytoreductive surgery alone
Number of subjects: 265
Study: 35974312

Group type: EXPERIMENTAL
Intervention: Single vision spectacle lenses with concentric rings of slightly aspherical contiguous lenslets technology (SAL)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Single vision lenses
Number of subjects: 100
Study: 32841748

Group type: EXPERIMENTAL
Intervention: Epicutaneous immunotherapy (DBV712 250 μg, daily epicutaneous peanut protein)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 253
Study: 35257614

Group type: EXPERIMENTAL
Intervention: Linear mixed effects model with random time effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Linear mixed effects model with random treatment effects
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Correctly specified model
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Classic stepped wedge cluster randomized trial with only 2 sequences
Number of subjects: 0
Study: 35141396

Group type: EXPERIMENTAL
Intervention: 40 Hz transcranial alternating current stimulation (tACS) for 30 days, 1-hour daily sessions
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham (placebo) tACS
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: 40 Hz transcranial alternating current stimulation (tACS)
Number of subjects: 50
Study: 36147126

Group type: EXPERIMENTAL
Intervention: HES 130/0.4
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ringer's bicarbonate
Number of subjects: 60
Study: 33150355

Group type: EXPERIMENTAL
Intervention: Caplacizumab
Number of subjects: 85
Study: 36106828

Group type: EXPERIMENTAL
Intervention: Intervention articles acknowledging the suicide (discussion with a psychologist, a friend of the decedent, or a suicide survivor)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Control article (no mention of the suicide)
Number of subjects: 425
Study: 34481729

Group type: EXPERIMENTAL
Intervention: Inhaled allergen-specific IgE antibody positivity measurement
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Specific IgE antibodies to inhaled allergens
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: IgE measurement to Japanese cedar pollen, D. pteronyssinus, and moths
Number of subjects: 800

Group type: EXPERIMENTAL
Intervention: Regional differences in pollen IgE positivity
Number of subjects: 800
Study: 33919529

Group type: EXPERIMENTAL
Intervention: Health literacy intervention
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Combined health literacy and exercise intervention
Number of subjects: 799

Group type: EXPERIMENTAL
Intervention: Physical activity (PA) levels
Number of subjects: 799
Study: 32945537

Group type: EXPERIMENTAL
Intervention: Fenfluramine hydrochloride (FFA), administered as add-on, twice daily at an initial dose of 0.2 mg/kg/d up to 0.7 mg/kg/d
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Fenfluramine hydrochloride (FFA)
Number of subjects: 52
Study: 33834887

Group type: EXPERIMENTAL
Intervention: Intramedullary nail (IMN) fixation
Number of subjects: 16

Group type: COMPARATOR
Intervention: K-wire fixation
Number of subjects: 16
Study: 33624705

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (N=18)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Placebo (N=14)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cholecalciferol (150 nM) in vitro
Number of subjects: 32

Group type: COMPARATOR
Intervention: Uremic serum in vitro
Number of subjects: 32
Study: 35057591

Group type: EXPERIMENTAL
Intervention: Cilnidipine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Amlodipine
Number of subjects: 100
Study: 33422704

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted education
Number of subjects: 388051

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted LDL-C levels
Number of subjects: 388051

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted BMI
Number of subjects: 388051

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted smoking
Number of subjects: 388051

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted SBP
Number of subjects: 388051

Group type: EXPERIMENTAL
Intervention: Genetically predicted education mediated through genetically predicted BMI and smoking
Number of subjects: 388051
Study: 33917677

Group type: EXPERIMENTAL
Intervention: Integrated oral healthcare intervention (dental assistance and collective health education actions in conversation circles)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Control group (usual assistance)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Low educational level of pregnant women
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Low family income (≤261.36 USD)
Number of subjects: 146
Study: 33228667

Group type: EXPERIMENTAL
Intervention: Peer-led community-based intervention for awareness generation on maternal and child health (MCH)
Number of subjects: 37324

Group type: EXPERIMENTAL
Intervention: Peer-led community-based intervention for livelihood scheme registration
Number of subjects: 37324

Group type: EXPERIMENTAL
Intervention: Peer-led community-based intervention for livelihood scheme participation
Number of subjects: 37324

Group type: EXPERIMENTAL
Intervention: Peer-led community-based intervention for women's awareness about MCH
Number of subjects: 37324

Group type: EXPERIMENTAL
Intervention: Peer-led community-based intervention for savings and financial management
Number of subjects: 37324
Study: 35260354

Group type: EXPERIMENTAL
Intervention: Chronic azithromycin
Number of subjects: 129

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study: 33129157

Group type: EXPERIMENTAL
Intervention: Prompt Mental Health Care (PMHC)
Number of subjects: 681

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 681

Group type: EXPERIMENTAL
Intervention: PMHC
Number of subjects: 681
Study: 32713797

Group type: EXPERIMENTAL
Intervention: Osia®
Number of subjects: 8

Group type: COMPARATOR
Intervention: Baha® Attract
Number of subjects: 8
Study: 32602742

Group type: EXPERIMENTAL
Intervention: Match-day (MD+1) assessment of mental fatigue (43±1 mm)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Late-season phase (MD+1) mental fatigue (34±2 mm)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Match success rate in late-season (80%)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Correlations between changes in MF and wellness variables
Number of subjects: 10
Study: 33368855

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35962351

Group type: EXPERIMENTAL
Intervention: Shared decision-making tool about anticoagulation
Number of subjects: 922

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 922
Study: 34164852

Group type: EXPERIMENTAL
Intervention: Boarding phase
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Cruising phase
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Estimated outside airflow rates in economy class
Number of subjects: 52

Group type: COMPARATOR
Intervention: Comparison with previous studies
Number of subjects: 52
Study: 33262189

Group type: EXPERIMENTAL
Intervention: Simvastatin as add-on to escitalopram
Number of subjects: 160

Group type: COMPARATOR
Intervention: Placebo as add-on to escitalopram
Number of subjects: 160
Study: 35904459

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 234

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 234
Study: 34948523

Group type: EXPERIMENTAL
Intervention: 10-week web-based parent-child physical activity program
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 36055668

Group type: EXPERIMENTAL
Intervention: Platelet-Rich Fibrin (PRF) application
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group (without PRF application)
Number of subjects: 40
Study: 33596735

Group type: EXPERIMENTAL
Intervention: Daily tenofovir/emtricitabine (TDF-FTC)
Number of subjects: 678
Study: 36150526

Group type: EXPERIMENTAL
Intervention: Obeticholic Acid (OCA)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control (Global PBC)
Number of subjects: 209

Group type: COMPARATOR
Intervention: Control (UK-PBC)
Number of subjects: 209
Study: 33468520

Group type: EXPERIMENTAL
Intervention: iGlarLixi
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prior GLP‐1 RA
Number of subjects: 0
Study: 33444208

Group type: EXPERIMENTAL
Intervention: Gabapentin (600 mg just before surgery and 600 mg/day for 2 days after surgery)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 35510611

Group type: EXPERIMENTAL
Intervention: ACTIVE cognitive training (memory, reasoning, and speed of processing)
Number of subjects: 2802

Group type: EXPERIMENTAL
Intervention: Baseline cognition
Number of subjects: 2802
Study: 34551412

Group type: EXPERIMENTAL
Intervention: Dental screening plus referral to a specific treating facility (intervention arm)
Number of subjects: 1098

Group type: COMPARATOR
Intervention: Screening plus advice letter to see a dentist (control arm)
Number of subjects: 1098
Study: 36172665

Group type: EXPERIMENTAL
Intervention: Home-based palliative care (three-month home visit)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no palliative care)
Number of subjects: 50
Study: 33541378

Group type: EXPERIMENTAL
Intervention: Lower extremity manipulation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Upper extremity manipulation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control (no manipulation)
Number of subjects: 0
Study: 36013230

Group type: EXPERIMENTAL
Intervention: Sanita mental health literacy educational programme (three 50-min classes)
Number of subjects: 125

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 125
Study: 33043552

Group type: EXPERIMENTAL
Intervention: Bisoprolol (5 mg daily for 2 weeks)
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Bisoprolol (up to 10 mg daily in open-label extension)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study: 34387038

Group type: EXPERIMENTAL
Intervention: Tamsulosin 0.2 mg orally once at night for 3 days starting on postoperative day 1 (treatment group)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Non-treatment (control group)
Number of subjects: 95
Study: 32096613

Group type: EXPERIMENTAL
Intervention: 40 mg/day SC elamipretide for 4 weeks
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo SC for 4 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 40 mg/day SC elamipretide
Number of subjects: 30
Study: 34999923

Group type: EXPERIMENTAL
Intervention: Foley catheter and controlled release dinoprostone
Number of subjects: 203

Group type: COMPARATOR
Intervention: Foley catheter alone
Number of subjects: 203
Study: 33872573

Group type: EXPERIMENTAL
Intervention: Negative Pressure Massage Treatment (NPMT)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Manual Lymphatic Drainage (MLD)
Number of subjects: 28
Study: 35338860

Group type: EXPERIMENTAL
Intervention: Probiotic peanut oral immunotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral immunotherapy and placebo
Number of subjects: 0
Study: 36174096

Group type: EXPERIMENTAL
Intervention: PARADIES intervention (combined cognitive behavioural therapy with case management)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Both groups (intervention and control)
Number of subjects: 236
Study: 33646267

Group type: EXPERIMENTAL
Intervention: Pharmacist-directed intervention (in-home assessment, educational resources, communication with primary care team, telephone follow-up)
Number of subjects: 361

Group type: COMPARATOR
Intervention: Control group (educational materials via mail)
Number of subjects: 361
Study: 35435430

Group type: EXPERIMENTAL
Intervention: Motivational interviewing retention counseling
Number of subjects: 0
Study: 36178574

Group type: EXPERIMENTAL
Intervention: Moderate hypoxic exposure for 4 weeks
Number of subjects: 9

Group type: COMPARATOR
Intervention: Sea level exposure for 4 weeks
Number of subjects: 9
Study: 34966711

Group type: EXPERIMENTAL
Intervention: Acupuncture and physical training
Number of subjects: 144

Group type: COMPARATOR
Intervention: Sham acupuncture and physical training
Number of subjects: 144

Group type: COMPARATOR
Intervention: Physical training
Number of subjects: 144
Study: 32911868

Group type: EXPERIMENTAL
Intervention: User fee exemption cards
Number of subjects: 1652
Study: 34714130

Group type: EXPERIMENTAL
Intervention: 100 g dried plum
Number of subjects: 66

Group type: COMPARATOR
Intervention: Control (0 g dried plum)
Number of subjects: 66
Study: 33584665

Group type: EXPERIMENTAL
Intervention: Probiotic supplementation (1 × 10^10 CFU Lactobacillus acidophilus DDS‐1 or 1 × 10^10 CFU Bifidobacterium animalis subsp. lactis UABla‐12)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study: 36202391

Group type: EXPERIMENTAL
Intervention: Mixed tree nuts (30 g/d for 4 weeks)
Number of subjects: 79

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 79
Study: 33586003

Group type: EXPERIMENTAL
Intervention: Salvia officinalis (SO) mouth rinse
Number of subjects: 88

Group type: COMPARATOR
Intervention: Normal saline (NS) mouth rinse
Number of subjects: 88
Study: 33308469

Group type: EXPERIMENTAL
Intervention: ChAdOx1 nCoV‐19 vaccine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35641232

Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposomal injection (VSLI) at 2.25 mg/m2
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposomal injection (VSLI) with bendamustine and rituximab (BR)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Vincristine sulfate liposomal injection (VSLI)
Number of subjects: 10
Study: 34823572

Group type: EXPERIMENTAL
Intervention: Prism adaptation treatment (twice-daily for two weeks)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Prism adaptation treatment
Number of subjects: 31